[1]
Y. J. Ali, N. B. A. Mohammad, I. M. Faisal, and M. M. Merkhan, “The triple impact of Enoxaparin: Moderating comorbidities, reducing hospitalization, and rationalizing medications”, Regul. Mech. Biosyst., vol. 16, no. 3, p. e25156, Oct. 2025.